CPT code 81511 designates a laboratory service that combines technical testing of four analytes — AFP, uE3, hCG, and DIA — with an algorithmic analysis incorporating patient data to produce a patient risk score. This type of multianalyte serum screening is clinically significant for stratifying risk in prenatal assessment and similar applications where biomarker panels inform clinical decision-making. Nationally, utilization of algorithm-based laboratory reporting has implications for coverage policy, clinical pathways, and laboratory workflows.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of the code, typical sites of service, common modifiers, and contextual guidance on where this service fits in laboratory and prenatal screening pathways. The publication summarizes payer coverage patterns, coding and billing considerations, and operational implications for laboratories that perform multianalyte testing with algorithmic risk reporting. Data not available in the input is noted where applicable, and the content focuses on national-level relevance for clinicians, laboratory administrators, and billing professionals.